📰 Program Updates News
Page 15 - Program Updates News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Program Updates. Real-time updates on events, politics, business and more.
October 20, 2022
Investegate announcements from atai Life Sciences, atai Life Sciences Announces R&D Day Agenda
October 18, 2022
The turboprop line now flies out of the factory on sustainable aviation fuel, with eco-challenge features incorporated into the Me & My TBM app.
August 16, 2022
16.08.2022 - On track to file New Drug Application for Renazorb, the first proprietary nanoparticle-based phosphate binder for Chronic Kidney Disease (CKD) patients, by end of 2023 Signed first global partnership for rights to Renazorb in China with Lee’s ...
August 15, 2022
Strong balance sheet of ~$324 million cash, cash equivalents and marketable securities as of June 30, 2022 is anticipated to fund planned operatio...
August 11, 2022
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...
August 11, 2022
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
August 11, 2022
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
August 9, 2022
09.08.2022 - Ensifentrine met primary and secondary endpoints of evaluating lung function in Phase 3 ENHANCE-2 trial for COPD Top-line Phase 3 ENHANCE-1 data expected around the end of 2022 Conference call today at 8:30 a.m. EDT / 1:30 p.m. ...
August 9, 2022
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace
August 9, 2022
Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submissi...